These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4414050)

  • 1. L-dopa induced plasma glucagon release.
    George DT; Rayfield EJ
    J Clin Endocrinol Metab; 1974 Sep; 39(3):618-21. PubMed ID: 4414050
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa stimulation of glucagon secretion in man.
    Rayfield EJ; George DT; Eichner HL; Hsu TH
    N Engl J Med; 1975 Sep; 293(12):589-91. PubMed ID: 1152893
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
    Klimes I; Vigas M; Jurcovicová J; Repceková D; Kolesár P
    Diabetes; 1978 Apr; 27(4):396-9. PubMed ID: 640244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adrenergic drugs on glucose and plasma glucagon and insulin responses to xylazine in sheep.
    Muggaberg J; Brockman RP
    Res Vet Sci; 1982 Jul; 33(1):118-20. PubMed ID: 6753074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa].
    Ragonese F; Melluso K; Campisi R; Carducci Artenisio A
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1969-74. PubMed ID: 1231881
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoreactive somatostatin in the hypothalamus and other regions of the rat brain: effects of insulin, glucose, alpha- or beta-blocker and L-dopa.
    Itoh M
    Endocrinol Jpn; 1979 Feb; 26(1):41-58. PubMed ID: 35344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
    Hampshire J; Moraru E; Altszuler N
    Pharmacology; 1978; 17(3):138-48. PubMed ID: 704657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.
    Vizner B; Reiner Z; Sekso M
    Exp Clin Endocrinol; 1983 Jan; 81(1):41-8. PubMed ID: 6343098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol enhancement of L-DOPA induced growth hormone stimulation.
    Camanni F; Massara F; Molinatti GM
    Biomedicine; 1974 Jun; 21(6):241-3. PubMed ID: 4441586
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of alpha-and beta-adrenergic inhibition and somatostatin on plasma glucose, free fatty acids, insulin glucagon and growth hormone responses to prostaglandin E1 in man.
    Giugliano D; Torella R; Sgambato S; D'Onofrio F
    J Clin Endocrinol Metab; 1979 Feb; 48(2):302-8. PubMed ID: 429484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of L-DOPA, phentolamine, aminophylline and propranolol on growth hormone secretion in patients with normal anterior pituitary function and subjects with acromegaly].
    De la Fuente E; Souvatzoglou A; von Werder K
    Verh Dtsch Ges Inn Med; 1974; 80():1325-8. PubMed ID: 4454412
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of L-dopa on plasma growth hormone, insulin, and thyroxine.
    Kansal PC; Buse J; Talbert OR; Buse MG
    J Clin Endocrinol Metab; 1972 Jan; 34(1):99-105. PubMed ID: 5061778
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
    Campbell PJ; Bolli GB; Cryer PE; Gerich JE
    N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
    Imura H; Nakai Y; Matsukura S; Matsuyama H
    Horm Metab Res; 1973 Jan; 5(1):41-5. PubMed ID: 4706921
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
    Maeda K; Kato Y; Chihara K; Ogo S; Iwasaki Y
    J Clin Endocrinol Metab; 1975 Aug; 41(2):408-11. PubMed ID: 239963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of adrenergic blockade on exercise-induced hyperglucagonemia.
    Harvey WD; Faloona GR; Unger RH
    Endocrinology; 1974 May; 94(5):1254-8. PubMed ID: 4823508
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma glucagon concentrations in sheep: their regulation and relation to concentrations of insulin and growth hormone.
    Bassett JM
    Aust J Biol Sci; 1972 Dec; 25(6):1277-87. PubMed ID: 4658437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.